M
Michael Moran
Researcher at Pfizer
Publications - 69
Citations - 11810
Michael Moran is an academic researcher from Pfizer. The author has contributed to research in topics: Medicine & SH2 domain. The author has an hindex of 28, co-authored 54 publications receiving 11332 citations. Previous affiliations of Michael Moran include McMaster University & Queen's University Belfast.
Papers
More filters
Journal ArticleDOI
Systematic identification of protein complexes in Saccharomyces cerevisiae by mass spectrometry
Yuen Ho,Albrecht Gruhler,Adrian Heilbut,Gary D. Bader,Gary D. Bader,Lynda Moore,Sally-Lin Adams,Anna Millar,Paul J. Taylor,Keiryn L. Bennett,Kelly Boutilier,Lingyun Yang,Cheryl Wolting,Ian Donaldson,Søren Schandorff,Juanita Shewnarane,Mai Vo,Joanne Taggart,Marilyn Goudreault,Brenda Muskat,Cris Alfarano,Danielle Dewar,Zhen Lin,Katerina Michalickova,Katerina Michalickova,Andrew Willems,Andrew Willems,Holly Sassi,Peter A Nielsen,Karina Juhl Rasmussen,Jens R. Andersen,Lene E. Johansen,Lykke Haastrup Hansen,Hans Jespersen,Alexandre V. Podtelejnikov,Eva Nielsen,Janne S. Crawford,Vibeke Poulsen,Birgitte D Sørensen,Jesper Matthiesen,Ronald C. Hendrickson,Frank Gleeson,Tony Pawson,Tony Pawson,Michael Moran,Daniel Durocher,Daniel Durocher,Matthias Mann,Christopher W. V. Hogue,Christopher W. V. Hogue,Daniel Figeys,Mike Tyers,Mike Tyers +52 more
TL;DR: Comparison of the HMS-PCI data set with interactions reported in the literature revealed an average threefold higher success rate in detection of known complexes compared with large-scale two-hybrid studies.
Journal ArticleDOI
SH2 and SH3 Domains: Elements that Control Interactions of Cytoplasmic Signaling Proteins
TL;DR: Observations suggest that SH2 and SH3 domains participate in the control of intracellular responses to growth factor stimulation.
Journal ArticleDOI
Large‐scale mapping of human protein–protein interactions by mass spectrometry
Rob M. Ewing,Peter Chu,Fred Elisma,Hongyan Li,Paul J. Taylor,Shane Climie,Linda McBroom-Cerajewski,Mark D. Robinson,Liam O'Connor,Michael Li,Rod Taylor,Moyez Dharsee,Yuen Ho,Adrian Heilbut,Lynda Moore,Shudong Zhang,Olga Ornatsky,Yury V. Bukhman,Martin Ethier,Yinglun Sheng,Julian Vasilescu,Mohamed Abu-Farha,Jean-Philippe Lambert,Henry S. Duewel,Ian I. Stewart,Bonnie Kuehl,Kelly Hogue,Karen Colwill,Katharine Gladwish,Brenda Muskat,Robert Kinach,Sally Lin Adams,Michael Moran,Gregg B. Morin,Thodoros Topaloglou,Daniel Figeys +35 more
TL;DR: In‐depth mining of the data set shows that it represents a valuable source of novel protein–protein interactions with relevance to human diseases, and via the preliminary analysis, many novel protein interactions and pathway associations are reported.
Journal ArticleDOI
Phosphorylation of GAP and GAP-associated proteins by transforming and mitogenic tyrosine kinases
TL;DR: It is shown that GAP, and two co-precipitating proteins of relative molecular masses 62,000 and 190,000 (p62 and p190) are phosphorylated on tyrosine in cells that have been transformed by cytoplasmic and receptor-like tyrosin kinases, which supports the idea that SH2 sequences direct the interactions of cytopLasmic proteins involved in signal transduction.
Journal ArticleDOI
Binding of SH2 domains of phospholipase C gamma 1, GAP, and Src to activated growth factor receptors
TL;DR: SH2 domains provide a common mechanism by which enzymatically diverse regulatory proteins can physically associate with the same activated receptors and thereby couple growth factor stimulation to intracellular signal transduction pathways.